Amy B. Yanke

Amy B. Yanke serves as Associate Professor of Neurology/Neurosurgery in the Department of Clinical Sciences at Auburn University's College of Veterinary Medicine, where she is board-certified by the American College of Veterinary Internal Medicine (ACVIM) in Neurology.

Her educational background includes:

• DVM from University of Georgia College of Veterinary Medicine (2012)
• MS from Purdue University (2017)

Dr. Yanke's research specializes in intracranial and spinal neoplasia within veterinary neurology, with emphasis on translational neuro-oncology that bridges veterinary and human medicine. Her work explores innovative therapies including oncolytic virotherapy, immunotherapy, and surgical interventions for brain and spinal cord tumors in canine models, directly contributing to the One Health initiative through comparative oncology studies.

Analysis of her 2017-2021 publications reveals a concentrated focus on canine gliomas and spinal neoplasia, featuring clinical trials of genetically engineered herpes simplex virus (M032) combined with checkpoint inhibitors. Her research spans neurosurgical techniques, emergency neurological care, and translational applications where canine spontaneous tumors serve as critical models for human high-grade gliomas.

Dr. Yanke actively participates in multi-institutional collaborations like the One Health Consortium, though specific grant details and student mentorship records aren't documented in the provided materials. Her clinical service within Auburn's neurology/neurosurgery department supports both patient care and translational research infrastructure.